Testing SPC1001 for essential hypertension
Part of Heart & circulation clinical trials.
This trial tests an oral medication called SPC1001 to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure not caused by another condition). It may help if you have mild to moderate high blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old.
- You have been diagnosed with high blood pressure (essential hypertension).
- At the screening visit, your blood pressure is high enough to qualify but not extremely high (under 180/110 mmHg).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving early blood pressure medication to people with slightly high blood pressure (stage 1) can help prevent future heart problems. If you qualify, you may receive treatment sooner to protect your heart and brain.
This trial tests a new medicine called SPC1001 Low to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure with no known cause). If you are between 19 and 75 years old and have mild to moderate high blood pressure, this study might be an option.
This study tests five new medicines to see if they can lower blood pressure in people with mild to moderate essential hypertension. It may help you if your blood pressure is not well controlled and you are willing to take the study medicine for a period of time.
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
This study tests a new blood pressure medication to see if it is safe and effective for people with high blood pressure. It may help lower your blood pressure and reduce health risks.
This early-stage trial tests a new oral medication (HS-10522) to see if it is safe and how the body handles it. It includes both healthy people and those with mild high blood pressure, and may help lower blood pressure in the future.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.